Sero-Prevalence of Bloodborne Tumor Viruses (HCV, HBV, HTLV-I and KSHV Infections) and Related Risk Factors among Prisoners in Razavi Khorasan Province, Iran, in 2008
Mohammad Khajedaluee
1
,
Ali Babaei
2
,
Rosita Vakili
3
,
Narges Valizade
1
,
Fateme Homaei Shandiz
4
,
Seyed Moayed Alavian
5
, 6
,
Mohsen Seyed Nozadi
1
,
Seyed Mohammad Jazayeri
7
and
Tahereh Hassannia
8
, *
1 Inflammation and Inflammatory Diseases Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, IR Iran
2 University of Applied Science and Technology, Mashhad Branch Region 6, (Prison Organization), Mashhad, IR Iran
3 Center of Pathological and Medical Diagnostic Services, Iranian Academic Center for Education, Culture and Research (ACECR), Mashhad Branch, Mashhad, IR Iran
4 Cancer Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, IR Iran
5 Baqiyatallah Research Center for Gastroenterology and Liver Diseases (BRCGL), Baqiyatallah University of Medical Sciences, Tehran, IR Iran
6 Middle East Liver Diseases (MELD) Center, Tehran, IR Iran
7 Hepatitis B Molecular Laboratory, Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, IR Iran
8 Internal Medicine Department, Arash Hospital, Tehran University of Medical Sciences, Tehran, IR Iran
Article information
Hepatitis Monthly: December 01, 2016, 16 (12); e31541
To Cite:
Khajedaluee
M, Babaei
A, Vakili
R, Valizade
N, Homaei Shandiz
F, et al. Sero-Prevalence of Bloodborne Tumor Viruses (HCV, HBV, HTLV-I and KSHV Infections) and Related Risk Factors among Prisoners in Razavi Khorasan Province, Iran, in 2008,
Hepat Mon.
2016
; 16(12):e31541.
doi: 10.5812/hepatmon.31541.
1.
Adjei AA,
Armah HB,
Gbagbo F,
Ampofo WK,
Boamah I,
Adu-Gyamfi C,
et al.
Correlates of HIV, HBV, HCV and syphilis infections among prison inmates and officers in Ghana: A national multicenter study. BMC Infect Dis. 2008; 8: 33[DOI][PubMed]
2.
Saha A, Kaul R, Murakami M, Robertson ES. Tumor viruses and cancer biology: Modulating signaling pathways for therapeutic intervention. Cancer Biol Ther. 2010; 10(10): 961-78[PubMed]
3.
Arjmand B,
Aghayan SH,
Goodarzi P,
Farzanehkhah M,
Mortazavi SM,
Niknam MH,
et al.
Seroprevalence of human T lymphtropic virus (HTLV) among tissue donors in Iranian tissue bank. Cell Tissue Bank. 2009; 10(3): 247-52[DOI][PubMed]
4.
Lam NC, Gotsch PB, Langan RC. Caring for pregnant women and newborns with hepatitis B or C. Am Fam Physician. 2010; 82(10): 1225-9[PubMed]
5.
Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev. 2006; 28: 112-25[DOI][PubMed]
6.
Tohme RA, Holmberg SD. Is sexual contact a major mode of hepatitis C virus transmission? Hepatology. 2010; 52(4): 1497-505[DOI][PubMed]
7.
Zhang T,
Shao X,
Chen Y,
Zhang T,
Minhas V,
Wood C,
et al.
Human herpesvirus 8 seroprevalence, China. Emerg Infect Dis. 2012; 18(1): 150-2[DOI][PubMed]
8.
Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC, Murphy EL. Global epidemiology of HTLV-I infection and associated diseases. Oncogene. 2005; 24(39): 6058-68[DOI][PubMed]
9.
Rafatpanah H,
Hedayati-Moghaddam MR,
Fathimoghadam F,
Bidkhori HR,
Shamsian SK,
Ahmadi S,
et al.
High prevalence of HTLV-I infection in Mashhad, Northeast Iran: a population-based seroepidemiology survey. J Clin Virol. 2011; 52(3): 172-6[DOI][PubMed]
10. Pebuara 2006. 2010;
11.
Rafatpanah H,
Rezaee A,
Etemadi MM,
Hosseini RF,
Khorram B,
Afsahr L,
et al.
The impact of interferon-alpha treatment on clinical and immunovirological aspects of HTLV-1-associated myelopathy in northeast of Iran. J Neuroimmunol. 2012; 250(1-2): 87-93[DOI][PubMed]
12.
Shoeibi A, Etemadi M, Moghaddam Ahmadi A, Amini M, Boostani R. "HTLV-I Infection" Twenty-Year Research in Neurology Department of Mashhad University of Medical Sciences. Iran J Basic Med Sci. 2013; 16(3): 202-7[PubMed]
13.
Kalavi K, Moradi A, Tabarraei A. Population-based Seroprevalence of HTLV-I Infection in Golestan Province, South East of Caspian Sea, Iran. Iran J Basic Med Sci. 2013; 16(3): 225-8[PubMed]
14.
Alter MJ. Epidemiology and prevention of hepatitis B. Semin Liver Dis. 2003; 23(1): 39-46[DOI][PubMed]
15.
Ott JJ, Stevens GA, Groeger J, Wiersma ST. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine. 2012; 30(12): 2212-9[DOI][PubMed]
16.
Ahmad B, Ali S, Ali I, Azam S, Bashir S. Response rates of standard interferon therapy in chronic HCV patients of Khyber Pakhtunkhwa (KPK). Virol J. 2012; 9: 18[DOI][PubMed]
17.
Ahmadi Ghezeldasht S,
Hassannia T,
Rafatpanah H,
Hekmat R,
Valizadeh N,
Ghayour Mobarhan M,
et al.
Oncogenic Virus Infections in the General Population and End-stage Renal Disease Patients With Special Emphasis on Kaposi's Sarcoma Associated Herpes Virus (KSHV) in Northeast of Iran. Jundishapur J Microbiol. 2015; 8(3)[DOI][PubMed]
18.
Ali A, Lal A. False positivity of serological tests for hepatitis C virus. J Ayub Med Coll Abbottabad. 2010; 22(2): 43-5[PubMed]
19.
Cobo F. Application of molecular diagnostic techniques for viral testing. Open Virol J. 2012; 6: 104-14[DOI][PubMed]
21.
Vazquez-Martinez JL, Coreno-Juarez MO, Montano-Estrada LF, Attlan M, Gomez-Dantes H. Seroprevalence of hepatitis B in pregnant women in Mexico. Salud Publica Mex. 2003; 45(3): 165-70[PubMed]
22. World prison population list 2007. 2007;
23. Report on the global AIDS epidemics. UNAIDS 10th Anniversary Special editio. 2006;
24.
Javadi AA, Avijgan M, Hafizi M. Prevalence of HBV and HCV infections and associated risk factors in addict prisoners. Iran J Public Health. 2006; 35(4): 33-6
25.
Burek V, Horvat J, Butorac K, Mikulic R. Viral hepatitis B, C and HIV infection in Croatian prisons. Epidemiol Infect. 2010; 138(11): 1610-20[DOI][PubMed]
26.
Mahfoud Z, Kassak K, Kreidieh K, Shamra S, Ramia S. Prevalence of antibodies to human immunodeficiency virus (HIV), hepatitis B and hepatitis C and risk factors in prisoners in Lebanon. J Infect Dev Ctries. 2010; 4(3): 144-9[PubMed]
27.
Nelwan EJ,
Van Crevel R,
Alisjahbana B,
Indrati AK,
Dwiyana RF,
Nuralam N,
et al.
Human immunodeficiency virus, hepatitis B and hepatitis C in an Indonesian prison: prevalence, risk factors and implications of HIV screening. Trop Med Int Health. 2010; 15(12): 1491-8[DOI][PubMed]
28.
Saiz de la Hoya P, Marco A, Garcia-Guerrero J, Rivera A, Prevalhep study G. Hepatitis C and B prevalence in Spanish prisons. Eur J Clin Microbiol Infect Dis. 2011; 30(7): 857-62[DOI][PubMed]
29.
Treso B,
Barcsay E,
Tarjan A,
Horvath G,
Dencs A,
Hettmann A,
et al.
Prevalence and correlates of HCV, HVB, and HIV infection among prison inmates and staff, Hungary. J Urban Health. 2012; 89(1): 108-16[DOI][PubMed]
30.
Amin-Esmaeili M, Rahimi-Movaghar A, Razaghi EM, Baghestani AR, Jafari S. Factors Correlated With Hepatitis C and B Virus Infections Among Injecting Drug Users in Tehran, IR Iran. Hepat Mon. 2012; 12(1): 23-31[DOI][PubMed]
31.
Azarkar Z, Sharifzadeh G. Evaluation of the Prevalence of Hepatitis B, Hepatitis C, and HIV in Inmates with Drug-Related Convictions in Birjand, Iran in 2008. Hepat Mon. 2010; 10(1): 26-30[PubMed]
32.
Ferlay J,
Soerjomataram I,
Dikshit R,
Eser S,
Mathers C,
Rebelo M,
et al.
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015; 136(5)-86[DOI][PubMed]
33.
Yasunaga J, Jeang KT. Viral transformation and aneuploidy. Environ Mol Mutagen. 2009; 50(8): 733-40[DOI][PubMed]
34.
Coelho HC,
de Oliveira SA,
Miguel JC,
Oliveira Mde L,
Figueiredo JF,
Perdona GC,
et al.
Predictive markers for hepatitis C virus infection among Brazilian inmates. Rev Soc Bras Med Trop. 2009; 42(4): 369-72[PubMed]
35.
Vescio MF,
Longo B,
Babudieri S,
Starnini G,
Carbonara S,
Rezza G,
et al.
Correlates of hepatitis C virus seropositivity in prison inmates: a meta-analysis. J Epidemiol Community Health. 2008; 62(4): 305-13[DOI][PubMed]
36.
Jalilvand S, Shoja Z, Mokhtari-Azad T, Nategh R, Gharehbaghian A. Seroprevalence of Human herpesvirus 8 (HHV-8) and incidence of Kaposi's sarcoma in Iran. Infect Agent Cancer. 2011; 6: 5[DOI][PubMed]
37.
Fathimoghaddam F, Hedayati-Moghaddam MR, Bidkhori HR, Ahmadi S, Sima HR. The prevalence of hepatitis B antigen-positivity in the general population of Mashhad, Iran. Hepat Mon. 2011; 11(5): 346-50[PubMed]
38.
Alavian SM. Hepatitis C virus infection: Epidemiology, risk factors and prevention strategies in public health in IR IRAN. Gastroenterol Hepatol Bed Bench. 2009; 3(1)
39.
Igakura T,
Stinchcombe JC,
Goon PK,
Taylor GP,
Weber JN,
Griffiths GM,
et al.
Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton. Science. 2003; 299(5613): 1713-6[DOI][PubMed]
40.
Ansaldi F,
Comar M,
D'Agaro P,
Grainfenberghi S,
Caimi L,
Gargiulo F,
et al.
Seroprevalence of HTLV-I and HTLV-II infection among immigrants in northern Italy. Eur J Epidemiol. 2003; 18(6): 583-8[PubMed]
41.
Catalan-Soares BC, Almeida RT, Carneiro-Proietti AB. Prevalence of HIV-1/2, HTLV-I/II, hepatitis B virus (HBV), hepatitis C virus (HCV), Treponema pallidum and Trypanosoma cruzi among prison inmates at Manhuacu, Minas Gerais State, Brazil. Rev Soc Bras Med Trop. 2000; 33(1): 27-30[PubMed]
42.
Fialho M,
Messias M,
Page-Shafer K,
Farre L,
Schmalb M,
Pedral-Sampaio D,
et al.
Prevalence and risk of blood-borne and sexually transmitted viral infections in incarcerated youth in Salvador, Brazil: opportunity and obligation for intervention. AIDS Behav. 2008; 12(4 Suppl)-24[DOI][PubMed]
43.
Sabbatani S, Giuliani R, Fulgaro C, Paolillo P, Baldi E, Chiodo F. [HIVAb, HCVAb and HBsAg seroprevalence among inmates of the prison of Bologna and the effect of counselling on the compliance of proposed tests]. Epidemiol Prev. 2004; 28(3): 163-8[PubMed]
44.
Adoga MP,
Banwat EB,
Forbi JC,
Nimzing L,
Pam CR,
Gyar SD,
et al.
Human immunonodeficiency virus, hepatitis B virus and hepatitis C virus: sero-prevalence, co-infection and risk factors among prison inmates in Nasarawa State, Nigeria. J Infect Dev Ctries. 2009; 3(7): 539-47[PubMed]
45.
Anwar MS, Nafees M, Nabi U. Sero-prevalence of HCV and associated infections with HIV and HBV among prisoners in Lahore. Biomedica. 2011; 27(2): 119-1122
Readers' Comments